12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Deals

Bristol-Myers, Gladstone Institutes deal

Bristol-Myers partnered with the institute to identify and validate targets that affect tau dysfunction in...

Read the full 52 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >